abrocitinib Report issue

Small molecule Approved FDA Breakthrough Therapy FDA Priority Review FDA

Active Ingredient History

NOW
  • Now
Abrocitinib, sold under the brand name Cibinqo, is a Janus kinase inhibitor medication used for the treatment of atopic dermatitis (eczema). It was developed by Pfizer.   Wikipedia

More Chemistry

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue